SWATH-MS for prospective identification of protein blood biomarkers of rtPA-associated intracranial hemorrhage in acute ischemic stroke: a pilot study

SWATH-MS for prospective identification of protein blood biomarkers of rtPA-associated intracranial hemorrhage in acute ischemic stroke: a pilot study

Abstract Intravenous recombinant tissue plasminogen activator (rtPA) is, besides mechanical thrombectomy, the highest class evidence based reperfusion treatment of acute ischemic stroke (AIS). The biggest concern of the therapy is symptomatic intracranial hemorrhage (sICH), which occurs in 3–7% of a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bartosz Karaszewski, Anna Gójska-Grymajło, Paulina Czaplewska, Bartosz Jabłoński, Aleksandra E. Lewandowska, Daria Ossowska, Adam Wyszomirski, Marek Hałas, Edyta Szurowska
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/96896a15699e4a57b8dea914c34db695
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:96896a15699e4a57b8dea914c34db695
record_format dspace
spelling oai:doaj.org-article:96896a15699e4a57b8dea914c34db6952021-12-02T15:14:48ZSWATH-MS for prospective identification of protein blood biomarkers of rtPA-associated intracranial hemorrhage in acute ischemic stroke: a pilot study10.1038/s41598-021-97710-92045-2322https://doaj.org/article/96896a15699e4a57b8dea914c34db6952021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-97710-9https://doaj.org/toc/2045-2322Abstract Intravenous recombinant tissue plasminogen activator (rtPA) is, besides mechanical thrombectomy, the highest class evidence based reperfusion treatment of acute ischemic stroke (AIS). The biggest concern of the therapy is symptomatic intracranial hemorrhage (sICH), which occurs in 3–7% of all treated patients, and is associated with worse functional outcome. Finding a method of the powerful identification of patients at highest risk of sICH, in order to increase the percentage of stroke patients safely treated with rtPA, is one of the most important challenges in stroke research. To address this problem, we designed a complex project to identify blood, neuroimaging, and clinical biomarkers combined for prospective assessment of the risk of rtPA-associated ICH. In this paper we present results of blood proteomic and peptide analysis of pilot 41 AIS patients before rtPA administration (the test ICH group, n = 9 or the controls, without ICH, n = 32). We demonstrated that pre-treatment blood profiles of 15 proteins differ depending on whether the patients develop rtPA-associated ICH or not. SWATH-MS quantification of serum or plasma proteins might allow for robust selection of blood biomarkers to increase the prospective assessment of rtPA-associated ICH over that based solely on clinical and neuroimaging characteristics.Bartosz KaraszewskiAnna Gójska-GrymajłoPaulina CzaplewskaBartosz JabłońskiAleksandra E. LewandowskaDaria OssowskaAdam WyszomirskiMarek HałasEdyta SzurowskaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Bartosz Karaszewski
Anna Gójska-Grymajło
Paulina Czaplewska
Bartosz Jabłoński
Aleksandra E. Lewandowska
Daria Ossowska
Adam Wyszomirski
Marek Hałas
Edyta Szurowska
SWATH-MS for prospective identification of protein blood biomarkers of rtPA-associated intracranial hemorrhage in acute ischemic stroke: a pilot study
description Abstract Intravenous recombinant tissue plasminogen activator (rtPA) is, besides mechanical thrombectomy, the highest class evidence based reperfusion treatment of acute ischemic stroke (AIS). The biggest concern of the therapy is symptomatic intracranial hemorrhage (sICH), which occurs in 3–7% of all treated patients, and is associated with worse functional outcome. Finding a method of the powerful identification of patients at highest risk of sICH, in order to increase the percentage of stroke patients safely treated with rtPA, is one of the most important challenges in stroke research. To address this problem, we designed a complex project to identify blood, neuroimaging, and clinical biomarkers combined for prospective assessment of the risk of rtPA-associated ICH. In this paper we present results of blood proteomic and peptide analysis of pilot 41 AIS patients before rtPA administration (the test ICH group, n = 9 or the controls, without ICH, n = 32). We demonstrated that pre-treatment blood profiles of 15 proteins differ depending on whether the patients develop rtPA-associated ICH or not. SWATH-MS quantification of serum or plasma proteins might allow for robust selection of blood biomarkers to increase the prospective assessment of rtPA-associated ICH over that based solely on clinical and neuroimaging characteristics.
format article
author Bartosz Karaszewski
Anna Gójska-Grymajło
Paulina Czaplewska
Bartosz Jabłoński
Aleksandra E. Lewandowska
Daria Ossowska
Adam Wyszomirski
Marek Hałas
Edyta Szurowska
author_facet Bartosz Karaszewski
Anna Gójska-Grymajło
Paulina Czaplewska
Bartosz Jabłoński
Aleksandra E. Lewandowska
Daria Ossowska
Adam Wyszomirski
Marek Hałas
Edyta Szurowska
author_sort Bartosz Karaszewski
title SWATH-MS for prospective identification of protein blood biomarkers of rtPA-associated intracranial hemorrhage in acute ischemic stroke: a pilot study
title_short SWATH-MS for prospective identification of protein blood biomarkers of rtPA-associated intracranial hemorrhage in acute ischemic stroke: a pilot study
title_full SWATH-MS for prospective identification of protein blood biomarkers of rtPA-associated intracranial hemorrhage in acute ischemic stroke: a pilot study
title_fullStr SWATH-MS for prospective identification of protein blood biomarkers of rtPA-associated intracranial hemorrhage in acute ischemic stroke: a pilot study
title_full_unstemmed SWATH-MS for prospective identification of protein blood biomarkers of rtPA-associated intracranial hemorrhage in acute ischemic stroke: a pilot study
title_sort swath-ms for prospective identification of protein blood biomarkers of rtpa-associated intracranial hemorrhage in acute ischemic stroke: a pilot study
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/96896a15699e4a57b8dea914c34db695
work_keys_str_mv AT bartoszkaraszewski swathmsforprospectiveidentificationofproteinbloodbiomarkersofrtpaassociatedintracranialhemorrhageinacuteischemicstrokeapilotstudy
AT annagojskagrymajło swathmsforprospectiveidentificationofproteinbloodbiomarkersofrtpaassociatedintracranialhemorrhageinacuteischemicstrokeapilotstudy
AT paulinaczaplewska swathmsforprospectiveidentificationofproteinbloodbiomarkersofrtpaassociatedintracranialhemorrhageinacuteischemicstrokeapilotstudy
AT bartoszjabłonski swathmsforprospectiveidentificationofproteinbloodbiomarkersofrtpaassociatedintracranialhemorrhageinacuteischemicstrokeapilotstudy
AT aleksandraelewandowska swathmsforprospectiveidentificationofproteinbloodbiomarkersofrtpaassociatedintracranialhemorrhageinacuteischemicstrokeapilotstudy
AT dariaossowska swathmsforprospectiveidentificationofproteinbloodbiomarkersofrtpaassociatedintracranialhemorrhageinacuteischemicstrokeapilotstudy
AT adamwyszomirski swathmsforprospectiveidentificationofproteinbloodbiomarkersofrtpaassociatedintracranialhemorrhageinacuteischemicstrokeapilotstudy
AT marekhałas swathmsforprospectiveidentificationofproteinbloodbiomarkersofrtpaassociatedintracranialhemorrhageinacuteischemicstrokeapilotstudy
AT edytaszurowska swathmsforprospectiveidentificationofproteinbloodbiomarkersofrtpaassociatedintracranialhemorrhageinacuteischemicstrokeapilotstudy
_version_ 1718387585173159936

Ejemplares similares